FNCMX
Price
$276.31
Change
-$0.07 (-0.03%)
Updated
Sep 5 closing price
Net Assets
20.92B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

FNCMX vs RGEBX

Header iconFNCMX vs RGEBX Comparison
Open Charts FNCMX vs RGEBXBanner chart's image
Fidelity Nasdaq Composite Index
Price$276.31
Change-$0.07 (-0.03%)
VolumeN/A
Net Assets20.92B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
FNCMX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNCMX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNCMX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. FNCMX (20.9B). FNCMX pays higher dividends than RGEBX: FNCMX (0.54) vs RGEBX (0.00). FNCMX was incepted earlier than RGEBX: FNCMX (22 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FNCMX (0.30). RGEBX is a more actively managed with annual turnover of: 25.00 vs. FNCMX (2.00). FNCMX has a lower initial minimum investment than RGEBX: FNCMX (0) vs RGEBX (250). FNCMX annual gain was more profitable for investors over the last year : 27.49 vs. RGEBX (17.59). FNCMX return over 5 years is better than : 99.90 vs. RGEBX (38.71).
FNCMXRGEBXFNCMX / RGEBX
Total Expense Ratio0.291.0927%
Annual Report Gross Expense Ratio0.301.0928%
Fund Existence22 years11 years-
Gain YTD12.88615.39884%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets20.9B332B6%
Annual Yield % from dividends0.540.00-
Returns for 1 year27.4917.59156%
Returns for 3 years92.8857.61161%
Returns for 5 years99.9038.71258%
Returns for 10 years348.6191.44381%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In